AGP Executive Report
Last update: 6 hours agoProduct Transparency: The Hemp Doctor says it now publishes independent lab certificates across its CBD, pet and other product lines, letting shoppers check potency and contaminants before buying. Hemp Policy: A marijuana reform group is urging Congress to protect hemp-derived THC products as new federal rules loom, keeping regulatory uncertainty in focus for hemp businesses. Australian Cannabis: Little Green Pharma has completed its all-share merger with Cannatrek, creating a larger group spanning cultivation, manufacturing, clinics and exports. Clinical Research: Neurotech International has dosed the first child in its pivotal trial of a cannabinoid-based autism treatment, a milestone for its development program. Community Investment: Vermont’s Magic Mann says its community fund has distributed more than $175,000, including over $75,000 for Indigenous people and organizations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.